Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/9536
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMIRANDA, Aline P. de-
dc.contributor.authorSILVA, Cely B.-
dc.contributor.authorMIMICA, Lycia M. J.-
dc.contributor.authorMOSCOVICI, Bernardo K.-
dc.contributor.authorMALAVAZZI, Gustavo R.-
dc.contributor.authorHIDA, Richard Y.-
dc.date.accessioned2015-07-01T20:57:23Z-
dc.date.available2015-07-01T20:57:23Z-
dc.date.issued2015-
dc.identifier.citationJOURNAL OF CATARACT AND REFRACTIVE SURGERY, v.41, n.1, p.135-139, 2015-
dc.identifier.issn0886-3350-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/9536-
dc.description.abstractPURPOSE: To evaluate the in vitro antimicrobial activity of aqueous humor in patients who had preoperative topical application of moxifloxacin hydrochloride 0.5%. SETTING: Department of Ophthalmology, Santa Casa de Misericordia de Sao Paulo, Brazil. DESIGN: Comparative case series. METHODS: Twenty-nine eyes from 29 cataract surgery patients were included in this study. In the study group (n = 15 eyes), 3 topical applications of moxifloxacin hydrochloride 0.5% were administered preoperatively; in the control group (n = 14 eyes), no topical applications were administered. Aqueous humor samples were collected and stored in sterile microtubes at -80 degrees C until analysis. Antimicrobial analysis was performed using standard strains with standard sterile filter paper disks. Inhibition halos were measured in millimeters, and both bactericidal and bacteriostatic effects were analyzed. RESULTS: Inhibition halos were observed on most of the study group plates except those with Streptococcus pneumoniae: Escherichia coli (13.93 mm +/- 0.64 [SD]), Klebsiella pneumoniae (10.63 +/- 0.61 mm), Staphylococcus aureus (7.47 +/- 0.68 mm), and S epidermidis (4.20 +/- 3.33 mm) The differences between the mean inhibition halo diameters were statistically significant (P < .0001) in all samples. No bactericidal effect was observed against any of the microorganisms studied. CONCLUSIONS: After topical application of moxifloxacin 0.5%, aqueous humor showed bacteriostatic effect against E coli, K pneumoniae, S aureus, and S epidermidis. No bactericidal effect was observed against any of the microorganisms evaluated. No antimicrobial effect against S pneumoniae was observed.-
dc.language.isoeng-
dc.publisherELSEVIER SCIENCE INC-
dc.relation.ispartofJournal of Cataract and Refractive Surgery-
dc.rightsrestrictedAccess-
dc.subject.othercataract-surgery-
dc.subject.othergatifloxacin 0.3-percent-
dc.subject.otherophthalmic solution-
dc.subject.otherendophthalmitis-
dc.subject.otherpenetration-
dc.subject.otherprophylaxis-
dc.subject.otherfluoroquinolones-
dc.subject.otherciprofloxacin-
dc.subject.otherantibiotics-
dc.subject.othereyedrops-
dc.titleIn vitro antimicrobial analysis of aqueous humor after topical application of moxifloxacin hydrochloride 0.5%-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER SCIENCE INC-
dc.identifier.doi10.1016/j.jcrs.2014.11.010-
dc.identifier.pmid25532640-
dc.subject.wosOphthalmology-
dc.subject.wosSurgery-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalMIRANDA, Aline P. de:Univ Sao Paulo, Santa Casa Misericordia Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil-
hcfmusp.author.externalSILVA, Cely B.:Univ Sao Paulo, Santa Casa Misericordia Sao Paulo, Dept Microbiol, Sao Paulo, Brazil-
hcfmusp.author.externalMIMICA, Lycia M. J.:Univ Sao Paulo, Santa Casa Misericordia Sao Paulo, Dept Microbiol, Sao Paulo, Brazil-
hcfmusp.author.externalMOSCOVICI, Bernardo K.:Univ Sao Paulo, Santa Casa Misericordia Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil-
hcfmusp.author.externalMALAVAZZI, Gustavo R.:Univ Sao Paulo, Santa Casa Misericordia Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil-
hcfmusp.description.beginpage135-
hcfmusp.description.endpage139-
hcfmusp.description.issue1-
hcfmusp.description.volume41-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84919430755-
hcfmusp.origem.idWOS:000347671300021-
hcfmusp.publisher.cityNEW YORK-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAaberg TM, 1998, OPHTHALMOLOGY, V105, P1004, DOI 10.1016/S0161-6420(98)96000-6-
hcfmusp.relation.referenceArbisser LB, 2008, J CATARACT REFR SURG, V34, P1114, DOI 10.1016/j.jcrs.2008.03.017-
hcfmusp.relation.referenceBalzli CL, 2010, J CATARACT REFR SURG, V36, P2160, DOI 10.1016/j.jcrs.2010.06.070-
hcfmusp.relation.referenceBERTI MA, 1975, ANTIMICROB AGENTS CH, V8, P633-
hcfmusp.relation.referenceCheung CSY, 2012, OPHTHALMOLOGY, V119, P1609, DOI 10.1016/j.ophtha.2012.02.014-
hcfmusp.relation.referenceCiulla TA, 2002, OPHTHALMOLOGY, V109, P13, DOI 10.1016/S0161-6420(01)00899-5-
hcfmusp.relation.referenceDEACON S, 1976, J CLIN PATHOL, V29, P749, DOI 10.1136/jcp.29.8.749-
hcfmusp.relation.referencede Kaspar HM, 2004, OPHTHALMOLOGY, V111, P1352, DOI 10.1016/j.ophtha.2003.10.032-
hcfmusp.relation.referenceBarry P, 2007, J CATARACT REFR SURG, V33, P978, DOI 10.1016/j.jcrs.2007.02.032-
hcfmusp.relation.referenceFaine S, 1968, LANCET, V292, P375, DOI 10.1016/S0140-6736(68)90593-X-
hcfmusp.relation.referenceGarcia-Saenz MC, 2001, J CATARACT REFR SURG, V27, P1969, DOI 10.1016/S0886-3350(01)00997-X-
hcfmusp.relation.referenceHariprasad SM, 2005, ARCH OPHTHALMOL-CHIC, V123, P39, DOI 10.1001/archopht.123.1.39-
hcfmusp.relation.referenceHarper T, 2007, OPHTHALMOLOGY, V114, P871, DOI 10.1016/j.ophtha.2007.01.007-
hcfmusp.relation.referenceJain GK, 2010, J PHARMACEUT BIOMED, V52, P110, DOI 10.1016/j.jpba.2009.12.008-
hcfmusp.relation.referenceJensen MK, 2008, J CATARACT REFR SURG, V34, P1460, DOI 10.1016/j.jcrs.2008.05.045-
hcfmusp.relation.referenceKim DH, 2005, OPHTHALMOLOGY, V112, P1992, DOI 10.1016/j.ophtha.2005.06.017-
hcfmusp.relation.referenceLevine JM, 2004, J CATARACT REFR SURG, V30, P2177, DOI 10.1016/j.jcrs.2004.06.048-
hcfmusp.relation.referenceMather R, 2004, AM J OPHTHALMOL, V138, P554, DOI 10.1016/j.ajo.2004.05.011-
hcfmusp.relation.referenceNational Committee for Clinical Laboratory Standards, 2003, PRACTICE RES NETWORK, V2, P1-
hcfmusp.relation.referenceOng-Tone L, 2008, J CATARACT REFR SURG, V34, P819, DOI 10.1016/j.jcrs.2007.12.041-
hcfmusp.relation.referenceOng-Tone L, 2007, J CATARACT REFR SURG, V33, P59, DOI 10.1016/j.jcrs.2006.09.015-
hcfmusp.relation.referenceSolomon R, 2005, OPHTHALMOLOGY, V112, P466, DOI 10.1016/j.ophtha.2004.09.029-
dc.description.indexMEDLINE-
dc.identifier.eissn1873-4502-
hcfmusp.citation.scopus4-
hcfmusp.scopus.lastupdate2024-03-28-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_MIRANDA_In_vitro_antimicrobial_analysis_of_aqueous_humor_after_2015.PDF
  Restricted Access
publishedVersion (English)249.43 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.